InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

- Current share price for ALC : $0.105

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$141 Investor Roadshow Presentation 29 Jun 2026 8:58AM $0.096 $0.105 risen by 9.37%
$141 Reconfirming FY26 Guidance and Acquisition Completion 29 Jun 2026 8:54AM $0.096 $0.105 risen by 9.37%
$141 Cleansing Notice 29 May 2026 8:51AM $0.110 $0.105 fallen by 4.55%
$141 Application for quotation of securities - ALC 29 May 2026 8:48AM $0.110 $0.105 fallen by 4.55%
$141 Proposed issue of securities - ALC 28 May 2026 3:40PM $0.108 $0.105 fallen by 2.33%
$141 ALC signs 7-year contract with UHSussex for EPR platform 25 May 2026 8:21AM $0.110 $0.105 fallen by 4.55%
$141 Acquisition of the Kyra flow products from Telstra Health 18 May 2026 8:57AM $0.099 $0.105 risen by 6.06%
$141 Q3 FY26 Quarterly Activities Report and Appendix 4C 29 Apr 2026 8:22AM $0.100 $0.105 risen by 5%
$141 Alcidion Q3 FY26 Results and Investor Webcast Notification 22 Apr 2026 5:03PM $0.105 $0.105 fallen by 0%
$141 H1 FY26 Results Presentation 26 Feb 2026 7:54AM $0.110 $0.105 fallen by 4.55%
$141 H1 FY26 Results Release 26 Feb 2026 7:54AM $0.110 $0.105 fallen by 4.55%
$141 H1 FY26 Appendix 4D and Half Year Report 26 Feb 2026 7:50AM $0.110 $0.105 fallen by 4.55%
$141 Alcidion H1 FY26 Results and Investor Webcast Notification 19 Feb 2026 10:10AM $0.105 $0.105 fallen by 0%
$141 Dual AU and UK Medical Device Registration for AI Capability 19 Feb 2026 10:06AM $0.105 $0.105 fallen by 0%
$141 Change in substantial holding 23 Jan 2026 8:25AM $0.120 $0.105 fallen by 12.50%
$141 Change in substantial holding 19 Jan 2026 5:20PM $0.125 $0.105 fallen by 16%
$141 Q2 FY26 Quarterly Activities Report and Appendix 4C 15 Jan 2026 8:46AM $0.140 $0.105 fallen by 25%
$141 Alcidion Q2 FY26 Results and Investor Webcast Notification 8 Jan 2026 10:55AM $0.110 $0.105 fallen by 4.55%
$141 Alcidion Selected as Preferred EPR Supplier 8 Jan 2026 8:24AM $0.099 $0.105 risen by 6.06%
$141 Notification regarding unquoted securities - ALC 26 Nov 2025 10:17AM $0.105 $0.105 fallen by 0%
$141 Alcidion expands contract with Leidos Australia 17 Nov 2025 8:24AM $0.098 $0.105 risen by 7.14%
$141 Notification of cessation of securities - ALC 31 Oct 2025 9:21AM $0.094 $0.105 risen by 11.70%
$141 Q1 FY26 Quarterly Activities Report and Appendix 4C 28 Oct 2025 8:23AM $0.098 $0.105 risen by 7.14%
$141 Alcidion Q1 FY26 Results and Investor Webcast Notification 22 Oct 2025 8:22AM $0.094 $0.105 risen by 11.70%
$141 Results of 2025 Annual General Meeting 16 Oct 2025 5:05PM $0.100 $0.105 risen by 5%

1 - 25 of 569 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.